Next, we evaluated the correlation between the IRGPs signature and clinical characteristics (age, gender, smoking, EGFR mutation, KARS mutation, radiotherapy, chemotherapy, TNM stage, tumor size, lymph node metastasis, and distant metastasis). The gene discussed is EGFR; the disease is neoplasm.